In April

Launched the “WINMED Giving from the Heart for Life: First Edition” project in collaboration with Ramathibodi Hospital, establishing a mobile blood and platelet donation unit at Winnergy Medical Public Company Limited.

In March

Winmed Clinic and Laboratory has enhanced its capacity as an HPV specimen collection unit accredited by the National Health Security Office (NHSO).

In January

• Certified with the ISO/IEC 27001:2022 international standard for Information Security Management System (ISMS).
• Received a license to operate a healthcare facility named "Winmed Sahaclinic."

In October

The company signed a Memorandum of Understanding (MOU) to support cervical cancer screening for women's health in collaboration with the Provincial Administrative Organization, with Nakhon Ratchasima being the first province.

In May

Received a certificate of compliance with the Personal Data Protection Act B.E. 2562 (PDPA)

In October

The Company started selling cervical cancer screening kits and sexually transmitted disease (HPV & STIs Self-Collect test) for all genders under the brand name "AVA".

The Company was appointed as a distributor for Thermo Fisher Scientific to distribute single-use products (S.U.T) used for bioprocessing to support research, production of biotechnology products, and food and drugs, etc. in Thailand.

In October

The Company launched a diagnostic laboratory business, with its starting operations for the diagnosis of coronavirus 2019.

In September

The Company has started to sell Antigen Test Kit (ATK) for Corona Virus 2019 (COVID 19) under the brand "JOYSBIO" and "LITUO".

In August

The Extraordinary General Meeting of Shareholders of WINMED, No. 1/2020 on August 28, 2020, resolved the approval of important issues as follows:

• The conversion from a limited company to a public company
• The change of par value from 10 baht of 5,500,000 shares to 0.50 baht, resulting in the total number of common shares of 110,000,000 shares
• The increase of registered capital by 85.00 million baht from the registered capital of 55.00 million baht to 140.00 million baht by issuing 170,000,000 new ordinary shares at a par value of 0.50 baht per share for offering to the existing shareholders
• The increase of registered capital by 60.00 million baht from the registered capital of 140.00 million baht to 200.00 million baht by issuing 120,000,000 new ordinary shares at a par value of 0.50 baht per share for initial public offering
• The approval to list the Company's ordinary shares as listed securities on the Market for Alternative Investment (mai)

In December

The Extraordinary General Meeting of Shareholders of WINMED, No. 1/2020 on August 28, 2020, resolved the approval of important issues as follows:

WINMED increased its registered capital from 5.00 million baht to 55.00 million baht, divided into 5,000,000 ordinary shares, at a par value of 10 baht per share for offering to the existing shareholders to use as working capital in the business.

In October

WHO invested in Professional Laboratory Management Corp, Co., Ltd., which operated the business of testing and diagnosis services.

In December

Biopool Company Limited (hereinafter referred to as "BP") was registered with an initial registered capital of 1.00 million baht, divided into 100,000 ordinary shares, at a par value of 10 baht per share, to operate the sales business of chemical products, scientific appliances, and medical equipment.

In August

Winnergy Holding Company Limited (hereinafter referred to as "WHO") was registered with an initial registered capital of 4.00 million baht, divided into 400,000 ordinary shares, at a par value of 10 baht per share to operate the import business of medical equipment and supplies from foreign manufacturers.